Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4H743
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.438 |
CLV_PCSK_FUR_1 | 45 | 49 | PF00082 | 0.490 |
CLV_PCSK_FUR_1 | 52 | 56 | PF00082 | 0.417 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 178 | 180 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 47 | 49 | PF00082 | 0.490 |
CLV_PCSK_PC7_1 | 48 | 54 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.456 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.444 |
DEG_APCC_DBOX_1 | 127 | 135 | PF00400 | 0.339 |
DEG_CRL4_CDT2_1 | 38 | 49 | PF00400 | 0.689 |
DEG_CRL4_CDT2_2 | 38 | 49 | PF00400 | 0.689 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.682 |
DEG_SCF_FBW7_1 | 1 | 7 | PF00400 | 0.601 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.780 |
DOC_CYCLIN_yCln2_LP_2 | 129 | 135 | PF00134 | 0.417 |
DOC_MAPK_DCC_7 | 128 | 136 | PF00069 | 0.339 |
DOC_MAPK_MEF2A_6 | 128 | 136 | PF00069 | 0.339 |
DOC_PP2B_LxvP_1 | 129 | 132 | PF13499 | 0.417 |
DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.698 |
DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.757 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.670 |
DOC_USP7_UBL2_3 | 178 | 182 | PF12436 | 0.738 |
DOC_WW_Pin1_4 | 188 | 193 | PF00397 | 0.672 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.739 |
LIG_14-3-3_CanoR_1 | 24 | 29 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 81 | 88 | PF00244 | 0.691 |
LIG_BRCT_BRCA1_1 | 96 | 100 | PF00533 | 0.564 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.308 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.631 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.673 |
LIG_LIR_Gen_1 | 25 | 35 | PF02991 | 0.593 |
LIG_LIR_Gen_1 | 93 | 101 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 93 | 99 | PF02991 | 0.534 |
LIG_MLH1_MIPbox_1 | 96 | 100 | PF16413 | 0.564 |
LIG_Pex14_1 | 96 | 100 | PF04695 | 0.550 |
LIG_SH2_GRB2like | 125 | 128 | PF00017 | 0.386 |
LIG_SH2_GRB2like | 157 | 160 | PF00017 | 0.542 |
LIG_SH2_NCK_1 | 28 | 32 | PF00017 | 0.671 |
LIG_SH2_SRC | 28 | 31 | PF00017 | 0.593 |
LIG_SH2_STAP1 | 28 | 32 | PF00017 | 0.652 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.624 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.629 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.274 |
LIG_TRAF2_1 | 187 | 190 | PF00917 | 0.606 |
LIG_TYR_ITIM | 26 | 31 | PF00017 | 0.585 |
MOD_CK1_1 | 113 | 119 | PF00069 | 0.277 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.693 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.556 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.660 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.600 |
MOD_CMANNOS | 142 | 145 | PF00535 | 0.289 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.381 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.444 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.474 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.492 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.412 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.226 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.711 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.557 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.607 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.390 |
MOD_N-GLC_1 | 7 | 12 | PF02516 | 0.499 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.595 |
MOD_NEK2_2 | 94 | 99 | PF00069 | 0.617 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.691 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.685 |
MOD_ProDKin_1 | 188 | 194 | PF00069 | 0.672 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.742 |
TRG_DiLeu_BaLyEn_6 | 83 | 88 | PF01217 | 0.624 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.583 |
TRG_ER_diArg_1 | 179 | 181 | PF00400 | 0.735 |
TRG_ER_diArg_1 | 52 | 55 | PF00400 | 0.636 |
TRG_NLS_MonoCore_2 | 177 | 182 | PF00514 | 0.731 |
TRG_NLS_MonoExtC_3 | 177 | 182 | PF00514 | 0.731 |
TRG_Pf-PMV_PEXEL_1 | 54 | 58 | PF00026 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 86 | 90 | PF00026 | 0.419 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE47 | Leptomonas seymouri | 75% | 100% |
A0A0S4J5J9 | Bodo saltans | 39% | 100% |
A0A1X0NNT8 | Trypanosomatidae | 43% | 96% |
A0A3Q8IHY4 | Leishmania donovani | 85% | 100% |
A0A3R7MTA4 | Trypanosoma rangeli | 50% | 100% |
A4HVI3 | Leishmania infantum | 85% | 100% |
D0A6S6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
E9AP78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4QGA0 | Leishmania major | 84% | 100% |
V5DBH6 | Trypanosoma cruzi | 48% | 100% |